[Form 4] Atlassian Corporation Insider Trading Activity
Rhea-AI Filing Summary
Michael Cannon-Brookes, CEO and Co-Founder of Atlassian Corporation (TEAM), reported multiple sales of Class A common stock on 08/29/2025 under a pre-established Rule 10b5-1 trading plan adopted February 20, 2025. The Form 4 lists four dispositions totaling 7,665 shares sold at weighted-average prices ranging from about $177.03 to $179.83 per share. After these transactions, the reporting person beneficially owned 160,965 Class A shares held indirectly through CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust. The filing is executed by an attorney-in-fact and discloses that the sales were effected in multiple trades during the day with price ranges noted in the footnotes.
Positive
- Transactions were conducted under a Rule 10b5-1 trading plan, adopted February 20, 2025, indicating pre-planned sales
- Full disclosure of weighted-average prices and intra-day price ranges is provided in the footnotes
- Filing identifies indirect ownership structure (CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust) enhancing transparency
Negative
- Insider sold a total of 7,665 Class A shares on 08/29/2025, reducing beneficial ownership to 160,965 shares
- Dispositions by the CEO and ~10% owner represent a measurable reduction in insider-held shares, which some investors may interpret negatively
Insights
TL;DR: The CEO executed planned sales of 7,665 shares via a 10b5-1 plan, modestly reducing indirect holdings to 160,965 shares.
The transactions were disclosed transparently with weighted-average prices and intra-day price ranges provided. Sales executed under a 10b5-1 plan reduce concerns about opportunistic timing but still represent a reduction in beneficial ownership by the company's largest insider. For investors, the dollar value of the trades (roughly mid-$177–$180 per share) is explicit in the filing; however, the filing does not provide the total dollar proceeds or the percentage change in ownership relative to total outstanding shares, so materiality to market capitalization cannot be judged from this form alone.
TL;DR: Sales were executed pursuant to a disclosed 10b5-1 plan, which strengthens procedural compliance but still reduces insider stake.
The filing clearly states the 10b5-1 plan adoption date and identifies indirect ownership via a trustee, which helps satisfy disclosure and governance norms. The attorney-in-fact signature and footnoted price ranges increase transparency. The filing does not indicate any amendments or other contemporaneous transactions beyond those listed, and it documents the reporting person’s roles (CEO, Director, ~10% owner), which is relevant for interpreting the governance impact of the ownership change.